Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation.

This study has been completed.
Sponsor:
Collaborator:
CSL Behring
Information provided by (Responsible Party):
Michael Campos, MD, University of Miami
ClinicalTrials.gov Identifier:
NCT01669421
First received: August 14, 2012
Last updated: May 30, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)